 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Principia Biopharma Inc. (PRNB)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-03-13 Sale | 2020-03-17 5:08 pm | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $48.56 | $242,816 | 116,903 (Indirect Direct) | View |
| 2020-03-16 Sale | 2020-03-18 5:08 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $46.15 | $254,031 | 35,609 (Direct) | View |
| 2020-05-01 Sale | 2020-05-05 8:07 pm | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $60.01 | $450,057 | 0 (Direct) | View |
| 2020-05-07 Sale | 2020-05-08 8:05 pm | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $60.16 | $360,941 | 30,968 (Direct) | View |
| 2020-05-19 Sale | 2020-05-21 8:01 pm | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 7,500 | $65.1 | $488,268 | 3,539 (Indirect Direct) | View |
| 2020-06-12 Sale | 2020-06-15 8:12 pm | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $61.16 | $305,788 | 117,761 (Indirect Direct) | View |
| 2019-12-16 Sale(A) | 2020-06-17 9:41 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,505 | $49.43 | $272,091 | 30,104 (Direct) | View |
| 2020-03-16 Sale(A) | 2020-06-17 9:48 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $46.15 | $254,031 | 24,600 (Direct) | View |
| 2020-06-15 Sale | 2020-06-17 9:52 pm | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $60.75 | $334,385 | 19,096 (Direct) | View |
| 2020-06-23 Sale | 2020-06-25 8:07 pm | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 15,000 | $61.86 | $927,889 | 810 (Indirect Direct) | View |
| 2020-07-01 Sale | 2020-07-02 8:48 pm | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $60 | $450,000 | 0 (Direct) | View |
| 2020-07-15 Sale | 2020-07-17 8:01 pm | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $80.07 | $1,201,069 | 1,826 (Direct) | View |
| 2020-08-10 Sale | 2020-08-12 8:01 pm | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $88.61 | $531,665 | 31,739 (Direct) | View |
| 2020-08-18 Sale | 2020-08-20 8:01 pm | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 7,500 | $99.37 | $745,240 | 3,539 (Indirect Direct) | View |
| 2020-08-18 Sale | 2020-08-20 8:17 pm | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $100 | $1,500,000 | 1,826 (Direct) | View |
| 2020-09-18 Sale | 2020-09-22 8:02 pm | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $99.98 | $499,917 | 117,761 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-05 Option Award | 2020-03-05 5:24 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Goldstein David Chief Scientific Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:26 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:27 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:28 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:30 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-17 5:08 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $4.7236 | 121,903 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-17 5:08 pm | N/A 2025-02-25 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $0 | 7,758 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 5:08 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $4.542 | 41,113 (Direct) | View |
| 2020-03-16 Exercise | 2020-03-18 5:08 pm | N/A 2027-02-15 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $0 | 19,047 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 8:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 840 | $4.542 | 840 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 8:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 6,660 | $4.542 | 6,660 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 8:07 pm | N/A 2027-06-26 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 840 | $0 | 61,884 (Direct) | View |
| 2020-05-01 Exercise | 2020-05-05 8:07 pm | N/A 2027-06-26 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 6,660 | $0 | 55,224 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-08 8:05 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $2.9977 | 36,968 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-08 8:05 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $0 | 2,447 (Direct) | View |
| 2020-05-19 Exercise | 2020-05-21 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 5,675 | $2.9977 | 11,039 (Direct) | View |
| 2020-05-19 Exercise | 2020-05-21 8:01 pm | N/A 2023-12-11 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 5,675 | $0 | 64,482 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:02 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:03 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Becker Daniel J. Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:05 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:08 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | George Simeon Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:10 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Machado Patrick Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:12 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Tomasello Shawn Director | 10,240 | $0 | 10,240 (Direct) | View |
| 2020-06-12 Exercise | 2020-06-15 8:12 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $4.7236 | 122,761 (Direct) | View |
| 2020-06-12 Exercise | 2020-06-15 8:12 pm | N/A 2025-02-25 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 5,000 | $0 | 2,758 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-25 8:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 15,000 | $2.9977 | 15,810 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-25 8:07 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 15,000 | $0 | 85,728 (Direct) | View |
| 2020-07-01 Exercise | 2020-07-02 8:48 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $4.542 | 7,500 (Direct) | View |
| 2020-07-01 Exercise | 2020-07-02 8:48 pm | N/A 2027-06-26 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 7,500 | $0 | 47,724 (Direct) | View |
| 2020-07-15 Exercise | 2020-07-17 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $23.77 | 16,826 (Direct) | View |
| 2020-07-15 Exercise | 2020-07-17 8:01 pm | N/A 2028-10-22 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $0 | 183,057 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 2,447 | $2.9977 | 34,186 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 3,553 | $3.1794 | 37,739 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 2,447 | $0 | 0 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A 2024-06-26 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 3,553 | $0 | 12,960 (Direct) | View |
| 2020-08-18 Purchase | 2020-08-20 4:30 pm | N/A 2020-11-20 | Principia Biopharma Inc. | PRNB | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 1,205 | $35.79 | 27,265 (Direct) | View |
| 2020-08-18 Purchase | 2020-08-20 4:30 pm | N/A 2020-11-20 | Principia Biopharma Inc. | PRNB | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 905 | $35.79 | 20,390 (Direct) | View |
| 2020-08-18 Purchase | 2020-08-20 4:30 pm | N/A 2020-11-20 | Principia Biopharma Inc. | PRNB | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 158 | $35.79 | 3,547 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 7,500 | $2.9977 | 11,039 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:01 pm | N/A 2023-12-11 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 7,500 | $0 | 56,982 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:17 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $23.77 | 16,826 (Direct) | View |
| 2020-08-18 Exercise | 2020-08-20 8:17 pm | N/A 2028-10-22 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 15,000 | $0 | 168,057 (Direct) | View |
| 2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 2,758 | $4.7236 | 120,519 (Direct) | View |
| 2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 2,242 | $7.2671 | 122,761 (Direct) | View |
| 2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A 2025-02-25 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 2,758 | $0 | 0 (Direct) | View |
| 2020-09-18 Exercise | 2020-09-22 8:02 pm | N/A 2027-12-13 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 2,242 | $0 | 11,519 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 1,023 | $100 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 39,179 | $100 | 0 (Indirect) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:07 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 18,355 | $100 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2022-12-29 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 255 | $0 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2022-07-02 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 50,795 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 85,728 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2024-06-26 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 110,085 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2024-12-25 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 83,004 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2025-07-20 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 60,546 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2027-12-13 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 115,590 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2028-08-23 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 187,144 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2029-02-28 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 155,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:07 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Babler Martin CEO | 200,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:08 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 31,826 | $100 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2024-06-26 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 12,960 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2024-12-25 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 13,210 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2024-12-25 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 8,807 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2025-07-20 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 15,412 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2026-03-14 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 22,017 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2027-12-13 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 34,677 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2028-08-23 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 44,034 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2029-02-28 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 60,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 75,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:11 pm | N/A N/A | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 3,799 | $100 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:11 pm | N/A N/A | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 3,302 | $100 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:11 pm | N/A 2023-12-11 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 56,982 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:11 pm | N/A 2024-06-26 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 24,769 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:11 pm | N/A 2024-12-25 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 29,723 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:11 pm | N/A 2025-07-20 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 13,210 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:11 pm | N/A 2027-12-13 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 34,677 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:11 pm | N/A 2028-08-23 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 44,034 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:11 pm | N/A 2029-02-28 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 60,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:11 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | CHAI CHRISTOPHER Y CFO | 55,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:14 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 117,761 | $100 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:14 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 1,916 | $100 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:14 pm | N/A 2027-12-13 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 11,519 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:14 pm | N/A 2028-08-23 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 44,034 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:14 pm | N/A 2029-02-28 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 60,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:14 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Hardiman Roy C. Chief Business Officer | 55,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:16 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 2,207 | $100 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:16 pm | N/A 2028-10-22 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 168,057 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:16 pm | N/A 2029-02-28 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 60,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:16 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Thomas Dolca Chief Medical Officer | 55,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Gift | 2020-09-28 5:19 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 5,504 | $0 | 13,592 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:19 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 13,592 | $100 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:19 pm | N/A 2027-02-15 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 30,056 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:19 pm | N/A 2027-12-13 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 16,843 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:19 pm | N/A 2028-08-23 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 22,017 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:19 pm | N/A 2028-08-27 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 55,042 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:19 pm | N/A 2029-02-28 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 60,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:19 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Wolff Stefani Chief Development Officer | 55,000 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:21 pm | N/A 2027-06-26 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 47,724 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:21 pm | N/A 2028-09-12 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 20,475 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:21 pm | N/A 2029-06-10 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:21 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Colowick Alan Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:24 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Becker Daniel J. Director | 667,600 | $100 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:24 pm | N/A 2028-09-12 | Principia Biopharma Inc. | PRNB | Becker Daniel J. Director | 20,475 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:24 pm | N/A 2029-06-10 | Principia Biopharma Inc. | PRNB | Becker Daniel J. Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:24 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Becker Daniel J. Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:25 pm | N/A 2029-04-15 | Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director | 20,475 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:25 pm | N/A 2029-06-10 | Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:25 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Lin Shao-Lee Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:27 pm | N/A N/A | Principia Biopharma Inc. | PRNB | George Simeon Director | 2,982,855 | $100 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:27 pm | N/A 2022-12-29 | Principia Biopharma Inc. | PRNB | George Simeon Director | 28,623 | $0 | 0 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:27 pm | N/A 2028-09-12 | Principia Biopharma Inc. | PRNB | George Simeon Director | 20,475 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:27 pm | N/A 2029-06-10 | Principia Biopharma Inc. | PRNB | George Simeon Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:27 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | George Simeon Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:28 pm | N/A 2029-06-10 | Principia Biopharma Inc. | PRNB | Machado Patrick Director | 20,475 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:28 pm | N/A 2029-06-10 | Principia Biopharma Inc. | PRNB | Machado Patrick Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:28 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Machado Patrick Director | 10,240 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:29 pm | N/A 2029-08-28 | Principia Biopharma Inc. | PRNB | Tomasello Shawn Director | 20,475 | $0 | 0 (Direct) | View |
| 2020-09-28 Disposition | 2020-09-28 5:29 pm | N/A 2030-06-03 | Principia Biopharma Inc. | PRNB | Tomasello Shawn Director | 10,240 | $0 | 0 (Direct) | View |